137 related articles for article (PubMed ID: 9920146)
1. Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia.
Saïdi Y; Sich D; Camproux A; Egloff M; Federspiel MC; Gautier V; Raisonnier A; Turpin G; Beucler I
Metabolism; 1999 Jan; 48(1):60-7. PubMed ID: 9920146
[TBL] [Abstract][Full Text] [Related]
2. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
Mero N; Van Tol A; Scheek LM; Van Gent T; Labeur C; Rosseneu M; Taskinen MR
J Lipid Res; 1998 Jul; 39(7):1493-502. PubMed ID: 9684753
[TBL] [Abstract][Full Text] [Related]
3. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase.
Mowri HO; Patsch JR; Ritsch A; Föger B; Brown S; Patsch W
J Lipid Res; 1994 Feb; 35(2):291-300. PubMed ID: 8169533
[TBL] [Abstract][Full Text] [Related]
4. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects.
Lassel TS; Guérin M; Auboiron S; Chapman MJ; Guy-Grand B
Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):65-74. PubMed ID: 9445258
[TBL] [Abstract][Full Text] [Related]
5. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
[TBL] [Abstract][Full Text] [Related]
6. Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
J Lipid Res; 2002 Oct; 43(10):1652-60. PubMed ID: 12364549
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of cholesteryl ester transfer in plasma by hormone-replacement therapy.
Ritsch A; Kaser S; Volgger B; Abfalter E; Sturm W; Gänzer H; Föger B; Kirchmair R; Ebenbichler C; Patsch JR
Metabolism; 2002 May; 51(5):599-604. PubMed ID: 11979392
[TBL] [Abstract][Full Text] [Related]
8. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
Tall A; Sammett D; Granot E
J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia.
Guerin M; Egger P; Le Goff W; Soudant C; Dupuis R; Chapman MJ
J Clin Endocrinol Metab; 2002 Nov; 87(11):4991-5000. PubMed ID: 12414863
[TBL] [Abstract][Full Text] [Related]
11. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.
Guan Y; Hou X; Tian P; Ren L; Tang Y; Song A; Zhao J; Gao L; Song G
Front Endocrinol (Lausanne); 2021; 12():646185. PubMed ID: 33967959
[TBL] [Abstract][Full Text] [Related]
12. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
14. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls.
Lottenberg SA; Lottenberg AM; Nunes VS; McPherson R; Quintão EC
Atherosclerosis; 1996 Nov; 127(1):81-90. PubMed ID: 9006808
[TBL] [Abstract][Full Text] [Related]
15. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
Contacos C; Barter PJ; Vrga L; Sullivan DR
Atherosclerosis; 1998 Nov; 141(1):87-98. PubMed ID: 9863541
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a cholesteryl ester donor activity of LDL particles during alimentary lipemia in normolipidemic subjects.
Lassel TS; Guerin M; Auboiron S; Guy-Grand B; Chapman MJ
Atherosclerosis; 1999 Nov; 147(1):41-8. PubMed ID: 10525123
[TBL] [Abstract][Full Text] [Related]
17. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
18. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
20. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
